Product Description
Boehringer Ingelheim is developing BI-1026706 as a treatment for Macular Edema. (Sourced from: https://classic.clinicaltrials.gov/ct2/show/NCT02732951)
Mechanisms of Action: B1 Antagonist
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Boehringer Ingelheim
Company Location: Europe
Company Founding Year: 1885
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 2: Macular Edema
Phase 1: Inflammation|Chronic Obstructive Pulmonary Disease|Healthy Volunteers|Osteoarthritis, Knee|Toothache|Pain, Postoperative
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT02657408 |
NCT02657408 | P1 |
Completed |
Healthy Volunteers |
2017-02-14 |
2019-07-12 |
Primary Completion Date|Start Date|Study Completion Date|Treatments |
|
NCT02652416 |
NCT02652416 | P1 |
Completed |
Healthy Volunteers |
2016-12-09 |
2019-07-12 |
Primary Completion Date|Start Date|Study Completion Date|Treatments |
|
NCT02642614 |
NCT02642614 | P1 |
Completed |
Inflammation|Chronic Obstructive Pulmonary Disease |
2016-06-14 |
2019-08-10 |
Primary Completion Date|Primary Endpoints|Start Date|Study Completion Date|Treatments |
|
NCT02513446 |
NCT02513446 | P1 |
Completed |
Healthy Volunteers |
2015-11-14 |
2019-03-31 |
Primary Completion Date|Start Date|Study Completion Date|Treatments |
|
NCT02084511 |
NCT02084511 | P1 |
Completed |
Pain, Postoperative|Toothache |
2014-10-01 |
2019-03-20 |
Treatments |
|
NCT02126826 |
NCT02126826 | P1 |
Completed |
Osteoarthritis, Knee |
2014-10-01 |
2019-03-27 |
||
NCT02037165 |
NCT02037165 | P1 |
Completed |
Healthy Volunteers |
2014-04-09 |
2019-07-10 |
Primary Completion Date|Start Date|Study Completion Date|Treatments |
|
NCT01763333 |
NCT01763333 | P1 |
Completed |
Healthy Volunteers |
2013-09-04 |
2019-03-27 |
Primary Completion Date|Start Date|Study Completion Date|Treatments |
|
2015-003529-33 |
2015-003529-33 | P2 |
Completed |
Macular Edema |
2017-10-24 |
2022-03-13 |
Treatments |
|
NCT02732951 |
NCT02732951 | P2 |
Completed |
Macular Edema |
2017-10-23 |
2019-03-22 |
Treatments |
